157 related articles for article (PubMed ID: 26469958)
1. p53 regulates the mevalonate pathway in human glioblastoma multiforme.
Laezza C; D'Alessandro A; Di Croce L; Picardi P; Ciaglia E; Pisanti S; Malfitano AM; Comegna M; Faraonio R; Gazzerro P; Bifulco M
Cell Death Dis; 2015 Oct; 6(10):e1909. PubMed ID: 26469958
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate Pathway and Human Cancers.
Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F
Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
[TBL] [Abstract][Full Text] [Related]
4. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.
Albertoni M; Shaw PH; Nozaki M; Godard S; Tenan M; Hamou MF; Fairlie DW; Breit SN; Paralkar VM; de Tribolet N; Van Meir EG; Hegi ME
Oncogene; 2002 Jun; 21(27):4212-9. PubMed ID: 12082608
[TBL] [Abstract][Full Text] [Related]
5. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
Moon SH; Huang CH; Houlihan SL; Regunath K; Freed-Pastor WA; Morris JP; Tschaharganeh DF; Kastenhuber ER; Barsotti AM; Culp-Hill R; Xue W; Ho YJ; Baslan T; Li X; Mayle A; de Stanchina E; Zender L; Tong DR; D'Alessandro A; Lowe SW; Prives C
Cell; 2019 Jan; 176(3):564-580.e19. PubMed ID: 30580964
[TBL] [Abstract][Full Text] [Related]
6. Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence.
Wei S; Liu L; Chen Z; Yin W; Liu Y; Ouyang Q; Zeng F; Nie Y; Chen T
J Cell Mol Med; 2020 Jan; 24(1):276-284. PubMed ID: 31746143
[TBL] [Abstract][Full Text] [Related]
7. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
Ma D; Nutt CL; Shanehsaz P; Peng X; Louis DN; Kaetzel DM
Cancer Res; 2005 Jul; 65(13):5523-34. PubMed ID: 15994924
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
Freed-Pastor WA; Mizuno H; Zhao X; Langerød A; Moon SH; Rodriguez-Barrueco R; Barsotti A; Chicas A; Li W; Polotskaia A; Bissell MJ; Osborne TF; Tian B; Lowe SW; Silva JM; Børresen-Dale AL; Levine AJ; Bargonetti J; Prives C
Cell; 2012 Jan; 148(1-2):244-58. PubMed ID: 22265415
[TBL] [Abstract][Full Text] [Related]
9. Disorder of the mevalonate pathway inhibits calcium-induced differentiation of keratinocytes.
Jin R; Luo X; Luan K; Liu L; Sun LD; Yang S; Zhang SQ; Zhang XJ
Mol Med Rep; 2017 Oct; 16(4):4811-4816. PubMed ID: 28765912
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cells.
Choi JW; Schroeder MA; Sarkaria JN; Bram RJ
Cancer Res; 2014 Jan; 74(2):484-96. PubMed ID: 24272483
[TBL] [Abstract][Full Text] [Related]
11. p53 protein overexpression in astrocytic neoplasms.
Cho MY; Jung SH; Kim TS
Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
[TBL] [Abstract][Full Text] [Related]
12. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
13. Farnesyl diphosphate synthase attenuates paclitaxel-induced apoptotic cell death in human glioblastoma U87MG cells.
Woo IS; Eun SY; Kim HJ; Kang ES; Kim HJ; Lee JH; Chang KC; Kim JH; Hong SC; Seo HG
Neurosci Lett; 2010 Apr; 474(2):115-20. PubMed ID: 20298756
[TBL] [Abstract][Full Text] [Related]
14. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
15. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A
Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820
[TBL] [Abstract][Full Text] [Related]
16. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
Zupanska A; Adach A; Dziembowska M; Kaminska B
Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
[TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
Straka MS; Panini SR
Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
[TBL] [Abstract][Full Text] [Related]
18. Survivin inhibits anti-growth effect of p53 activated by aurora B.
Jung JE; Kim TK; Lee JS; Oh SY; Kwak S; Jin X; Sohn JY; Song MK; Sohn YW; Lee SY; Pian X; Lee JB; Chung YG; Choi YK; You S; Kim H
Biochem Biophys Res Commun; 2005 Nov; 336(4):1164-71. PubMed ID: 16171786
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of farnesyl diphosphate pool as direct precursor of sesquiterpenes through metabolic engineering of the mevalonate pathway in Saccharomyces cerevisiae.
Asadollahi MA; Maury J; Schalk M; Clark A; Nielsen J
Biotechnol Bioeng; 2010 May; 106(1):86-96. PubMed ID: 20091767
[TBL] [Abstract][Full Text] [Related]
20. Coenzyme Q10 in phenylketonuria and mevalonic aciduria.
Hargreaves IP
Mitochondrion; 2007 Jun; 7 Suppl():S175-80. PubMed ID: 17442628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
